nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—SLC6A4—Alzheimer's disease	0.693	1	CbGaD
Milnacipran—SLC6A2—locus ceruleus—Alzheimer's disease	0.0174	0.526	CbGeAlD
Milnacipran—SLC6A4—forebrain—Alzheimer's disease	0.00245	0.0741	CbGeAlD
Milnacipran—SLC6A4—telencephalon—Alzheimer's disease	0.00225	0.0681	CbGeAlD
Milnacipran—SLC6A2—forebrain—Alzheimer's disease	0.00215	0.0652	CbGeAlD
Milnacipran—SLC6A2—telencephalon—Alzheimer's disease	0.00198	0.0599	CbGeAlD
Milnacipran—Pethidine—GRIN2B—Alzheimer's disease	0.00191	0.341	CrCbGaD
Milnacipran—Levomilnacipran—SLC6A4—Alzheimer's disease	0.00149	0.267	CrCbGaD
Milnacipran—SLC6A4—nervous system—Alzheimer's disease	0.00133	0.0402	CbGeAlD
Milnacipran—SLC6A4—central nervous system—Alzheimer's disease	0.00128	0.0387	CbGeAlD
Milnacipran—SLC6A2—nervous system—Alzheimer's disease	0.00117	0.0354	CbGeAlD
Milnacipran—SLC6A2—central nervous system—Alzheimer's disease	0.00113	0.0341	CbGeAlD
Milnacipran—Levomilnacipran—CYP2D6—Alzheimer's disease	0.00105	0.188	CrCbGaD
Milnacipran—SLC6A4—brain—Alzheimer's disease	0.00101	0.0307	CbGeAlD
Milnacipran—SLC6A2—brain—Alzheimer's disease	0.000893	0.0271	CbGeAlD
Milnacipran—Dysuria—Donepezil—Alzheimer's disease	0.000814	0.00308	CcSEcCtD
Milnacipran—Breast disorder—Rivastigmine—Alzheimer's disease	0.000808	0.00306	CcSEcCtD
Milnacipran—Pollakiuria—Donepezil—Alzheimer's disease	0.000804	0.00304	CcSEcCtD
Milnacipran—Mental disorder—Galantamine—Alzheimer's disease	0.000788	0.00298	CcSEcCtD
Milnacipran—Weight decreased—Donepezil—Alzheimer's disease	0.000787	0.00298	CcSEcCtD
Milnacipran—Malnutrition—Galantamine—Alzheimer's disease	0.000783	0.00296	CcSEcCtD
Milnacipran—Flatulence—Galantamine—Alzheimer's disease	0.000771	0.00292	CcSEcCtD
Milnacipran—Angina pectoris—Memantine—Alzheimer's disease	0.00077	0.00291	CcSEcCtD
Milnacipran—Tension—Galantamine—Alzheimer's disease	0.000768	0.00291	CcSEcCtD
Milnacipran—Dysgeusia—Galantamine—Alzheimer's disease	0.000766	0.0029	CcSEcCtD
Milnacipran—Urinary tract infection—Donepezil—Alzheimer's disease	0.000754	0.00286	CcSEcCtD
Milnacipran—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000753	0.00285	CcSEcCtD
Milnacipran—Haematuria—Donepezil—Alzheimer's disease	0.00074	0.0028	CcSEcCtD
Milnacipran—Neutropenia—Memantine—Alzheimer's disease	0.000739	0.0028	CcSEcCtD
Milnacipran—Dysuria—Memantine—Alzheimer's disease	0.000739	0.0028	CcSEcCtD
Milnacipran—Vision blurred—Galantamine—Alzheimer's disease	0.000737	0.00279	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000734	0.00278	CcSEcCtD
Milnacipran—Tremor—Galantamine—Alzheimer's disease	0.000733	0.00278	CcSEcCtD
Milnacipran—Pollakiuria—Memantine—Alzheimer's disease	0.00073	0.00276	CcSEcCtD
Milnacipran—Erectile dysfunction—Memantine—Alzheimer's disease	0.000728	0.00276	CcSEcCtD
Milnacipran—Dysuria—Rivastigmine—Alzheimer's disease	0.000723	0.00274	CcSEcCtD
Milnacipran—Agitation—Galantamine—Alzheimer's disease	0.000719	0.00272	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000718	0.00272	CcSEcCtD
Milnacipran—Weight decreased—Memantine—Alzheimer's disease	0.000715	0.00271	CcSEcCtD
Milnacipran—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000714	0.0027	CcSEcCtD
Milnacipran—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000712	0.0027	CcSEcCtD
Milnacipran—Syncope—Galantamine—Alzheimer's disease	0.000702	0.00266	CcSEcCtD
Milnacipran—Weight decreased—Rivastigmine—Alzheimer's disease	0.000699	0.00265	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000699	0.00265	CcSEcCtD
Milnacipran—Hepatitis—Donepezil—Alzheimer's disease	0.000697	0.00264	CcSEcCtD
Milnacipran—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000693	0.00262	CcSEcCtD
Milnacipran—Hallucination—Donepezil—Alzheimer's disease	0.000693	0.00262	CcSEcCtD
Milnacipran—Palpitations—Galantamine—Alzheimer's disease	0.000692	0.00262	CcSEcCtD
Milnacipran—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000688	0.00261	CcSEcCtD
Milnacipran—Loss of consciousness—Galantamine—Alzheimer's disease	0.000688	0.0026	CcSEcCtD
Milnacipran—Oedema peripheral—Donepezil—Alzheimer's disease	0.000686	0.0026	CcSEcCtD
Milnacipran—Urinary tract infection—Memantine—Alzheimer's disease	0.000685	0.00259	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000683	0.00259	CcSEcCtD
Milnacipran—Urethral disorder—Donepezil—Alzheimer's disease	0.000683	0.00259	CcSEcCtD
Milnacipran—Convulsion—Galantamine—Alzheimer's disease	0.000678	0.00257	CcSEcCtD
Milnacipran—Hypertension—Galantamine—Alzheimer's disease	0.000676	0.00256	CcSEcCtD
Milnacipran—Pethidine—SLC6A4—Alzheimer's disease	0.000673	0.12	CrCbGaD
Milnacipran—Haematuria—Memantine—Alzheimer's disease	0.000672	0.00254	CcSEcCtD
Milnacipran—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00067	0.00254	CcSEcCtD
Milnacipran—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000666	0.00252	CcSEcCtD
Milnacipran—Chest pain—Galantamine—Alzheimer's disease	0.000666	0.00252	CcSEcCtD
Milnacipran—Anxiety—Galantamine—Alzheimer's disease	0.000664	0.00251	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000662	0.00251	CcSEcCtD
Milnacipran—Haematuria—Rivastigmine—Alzheimer's disease	0.000657	0.00249	CcSEcCtD
Milnacipran—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000652	0.00247	CcSEcCtD
Milnacipran—Dry mouth—Galantamine—Alzheimer's disease	0.000652	0.00247	CcSEcCtD
Milnacipran—Hepatitis—Memantine—Alzheimer's disease	0.000633	0.0024	CcSEcCtD
Milnacipran—Hypoaesthesia—Memantine—Alzheimer's disease	0.000629	0.00238	CcSEcCtD
Milnacipran—Hallucination—Memantine—Alzheimer's disease	0.000629	0.00238	CcSEcCtD
Milnacipran—Shock—Galantamine—Alzheimer's disease	0.000628	0.00238	CcSEcCtD
Milnacipran—Nervous system disorder—Galantamine—Alzheimer's disease	0.000626	0.00237	CcSEcCtD
Milnacipran—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000625	0.00237	CcSEcCtD
Milnacipran—Chills—Donepezil—Alzheimer's disease	0.000625	0.00237	CcSEcCtD
Milnacipran—Urinary tract disorder—Memantine—Alzheimer's disease	0.000625	0.00237	CcSEcCtD
Milnacipran—Tachycardia—Galantamine—Alzheimer's disease	0.000623	0.00236	CcSEcCtD
Milnacipran—Oedema peripheral—Memantine—Alzheimer's disease	0.000623	0.00236	CcSEcCtD
Milnacipran—Connective tissue disorder—Memantine—Alzheimer's disease	0.000622	0.00235	CcSEcCtD
Milnacipran—Skin disorder—Galantamine—Alzheimer's disease	0.00062	0.00235	CcSEcCtD
Milnacipran—Urethral disorder—Memantine—Alzheimer's disease	0.00062	0.00235	CcSEcCtD
Milnacipran—Hepatitis—Rivastigmine—Alzheimer's disease	0.000619	0.00234	CcSEcCtD
Milnacipran—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000617	0.00234	CcSEcCtD
Milnacipran—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000616	0.00233	CcSEcCtD
Milnacipran—Hallucination—Rivastigmine—Alzheimer's disease	0.000616	0.00233	CcSEcCtD
Milnacipran—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000611	0.00231	CcSEcCtD
Milnacipran—Mental disorder—Donepezil—Alzheimer's disease	0.00061	0.00231	CcSEcCtD
Milnacipran—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00061	0.00231	CcSEcCtD
Milnacipran—Anorexia—Galantamine—Alzheimer's disease	0.000609	0.00231	CcSEcCtD
Milnacipran—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000608	0.0023	CcSEcCtD
Milnacipran—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000607	0.0023	CcSEcCtD
Milnacipran—Malnutrition—Donepezil—Alzheimer's disease	0.000606	0.0023	CcSEcCtD
Milnacipran—Erythema multiforme—Memantine—Alzheimer's disease	0.000598	0.00226	CcSEcCtD
Milnacipran—Flatulence—Donepezil—Alzheimer's disease	0.000598	0.00226	CcSEcCtD
Milnacipran—Hypotension—Galantamine—Alzheimer's disease	0.000597	0.00226	CcSEcCtD
Milnacipran—Tension—Donepezil—Alzheimer's disease	0.000595	0.00225	CcSEcCtD
Milnacipran—Dysgeusia—Donepezil—Alzheimer's disease	0.000594	0.00225	CcSEcCtD
Milnacipran—Eye disorder—Memantine—Alzheimer's disease	0.000591	0.00224	CcSEcCtD
Milnacipran—Flushing—Memantine—Alzheimer's disease	0.000587	0.00222	CcSEcCtD
Milnacipran—Cardiac disorder—Memantine—Alzheimer's disease	0.000587	0.00222	CcSEcCtD
Milnacipran—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000585	0.00222	CcSEcCtD
Milnacipran—Eye disorder—Rivastigmine—Alzheimer's disease	0.000578	0.00219	CcSEcCtD
Milnacipran—Insomnia—Galantamine—Alzheimer's disease	0.000578	0.00219	CcSEcCtD
Milnacipran—Flushing—Rivastigmine—Alzheimer's disease	0.000574	0.00217	CcSEcCtD
Milnacipran—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000574	0.00217	CcSEcCtD
Milnacipran—Angiopathy—Memantine—Alzheimer's disease	0.000574	0.00217	CcSEcCtD
Milnacipran—Paraesthesia—Galantamine—Alzheimer's disease	0.000573	0.00217	CcSEcCtD
Milnacipran—Vision blurred—Donepezil—Alzheimer's disease	0.000572	0.00216	CcSEcCtD
Milnacipran—Mediastinal disorder—Memantine—Alzheimer's disease	0.00057	0.00216	CcSEcCtD
Milnacipran—Tremor—Donepezil—Alzheimer's disease	0.000568	0.00215	CcSEcCtD
Milnacipran—Somnolence—Galantamine—Alzheimer's disease	0.000568	0.00215	CcSEcCtD
Milnacipran—Chills—Memantine—Alzheimer's disease	0.000568	0.00215	CcSEcCtD
Milnacipran—Dyspepsia—Galantamine—Alzheimer's disease	0.000562	0.00213	CcSEcCtD
Milnacipran—Angiopathy—Rivastigmine—Alzheimer's disease	0.000561	0.00213	CcSEcCtD
Milnacipran—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000558	0.00211	CcSEcCtD
Milnacipran—Agitation—Donepezil—Alzheimer's disease	0.000557	0.00211	CcSEcCtD
Milnacipran—Chills—Rivastigmine—Alzheimer's disease	0.000555	0.0021	CcSEcCtD
Milnacipran—Decreased appetite—Galantamine—Alzheimer's disease	0.000555	0.0021	CcSEcCtD
Milnacipran—Mental disorder—Memantine—Alzheimer's disease	0.000554	0.0021	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000551	0.00209	CcSEcCtD
Milnacipran—Malnutrition—Memantine—Alzheimer's disease	0.000551	0.00208	CcSEcCtD
Milnacipran—Fatigue—Galantamine—Alzheimer's disease	0.000551	0.00208	CcSEcCtD
Milnacipran—Constipation—Galantamine—Alzheimer's disease	0.000546	0.00207	CcSEcCtD
Milnacipran—Syncope—Donepezil—Alzheimer's disease	0.000544	0.00206	CcSEcCtD
Milnacipran—Flatulence—Memantine—Alzheimer's disease	0.000543	0.00205	CcSEcCtD
Milnacipran—Mental disorder—Rivastigmine—Alzheimer's disease	0.000542	0.00205	CcSEcCtD
Milnacipran—Tension—Memantine—Alzheimer's disease	0.00054	0.00205	CcSEcCtD
Milnacipran—Dysgeusia—Memantine—Alzheimer's disease	0.000539	0.00204	CcSEcCtD
Milnacipran—Malnutrition—Rivastigmine—Alzheimer's disease	0.000539	0.00204	CcSEcCtD
Milnacipran—Loss of consciousness—Donepezil—Alzheimer's disease	0.000533	0.00202	CcSEcCtD
Milnacipran—Flatulence—Rivastigmine—Alzheimer's disease	0.000531	0.00201	CcSEcCtD
Milnacipran—Tension—Rivastigmine—Alzheimer's disease	0.000529	0.002	CcSEcCtD
Milnacipran—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000527	0.002	CcSEcCtD
Milnacipran—Convulsion—Donepezil—Alzheimer's disease	0.000525	0.00199	CcSEcCtD
Milnacipran—Hypertension—Donepezil—Alzheimer's disease	0.000524	0.00198	CcSEcCtD
Milnacipran—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000522	0.00198	CcSEcCtD
Milnacipran—Vision blurred—Memantine—Alzheimer's disease	0.000519	0.00196	CcSEcCtD
Milnacipran—Chest pain—Donepezil—Alzheimer's disease	0.000516	0.00195	CcSEcCtD
Milnacipran—Tremor—Memantine—Alzheimer's disease	0.000516	0.00195	CcSEcCtD
Milnacipran—Anxiety—Donepezil—Alzheimer's disease	0.000515	0.00195	CcSEcCtD
Milnacipran—Vision blurred—Rivastigmine—Alzheimer's disease	0.000508	0.00192	CcSEcCtD
Milnacipran—Agitation—Memantine—Alzheimer's disease	0.000506	0.00192	CcSEcCtD
Milnacipran—Dry mouth—Donepezil—Alzheimer's disease	0.000505	0.00191	CcSEcCtD
Milnacipran—Abdominal pain—Galantamine—Alzheimer's disease	0.000505	0.00191	CcSEcCtD
Milnacipran—Body temperature increased—Galantamine—Alzheimer's disease	0.000505	0.00191	CcSEcCtD
Milnacipran—Tremor—Rivastigmine—Alzheimer's disease	0.000505	0.00191	CcSEcCtD
Milnacipran—Agitation—Rivastigmine—Alzheimer's disease	0.000495	0.00187	CcSEcCtD
Milnacipran—Syncope—Memantine—Alzheimer's disease	0.000494	0.00187	CcSEcCtD
Milnacipran—Leukopenia—Memantine—Alzheimer's disease	0.000493	0.00187	CcSEcCtD
Milnacipran—Infection—Donepezil—Alzheimer's disease	0.000492	0.00186	CcSEcCtD
Milnacipran—Shock—Donepezil—Alzheimer's disease	0.000487	0.00184	CcSEcCtD
Milnacipran—Palpitations—Memantine—Alzheimer's disease	0.000487	0.00184	CcSEcCtD
Milnacipran—Nervous system disorder—Donepezil—Alzheimer's disease	0.000485	0.00184	CcSEcCtD
Milnacipran—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000485	0.00183	CcSEcCtD
Milnacipran—Loss of consciousness—Memantine—Alzheimer's disease	0.000484	0.00183	CcSEcCtD
Milnacipran—Syncope—Rivastigmine—Alzheimer's disease	0.000483	0.00183	CcSEcCtD
Milnacipran—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000478	0.00181	CcSEcCtD
Milnacipran—Convulsion—Memantine—Alzheimer's disease	0.000477	0.00181	CcSEcCtD
Milnacipran—Palpitations—Rivastigmine—Alzheimer's disease	0.000476	0.0018	CcSEcCtD
Milnacipran—Hypertension—Memantine—Alzheimer's disease	0.000475	0.0018	CcSEcCtD
Milnacipran—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000473	0.00179	CcSEcCtD
Milnacipran—Pethidine—CYP2D6—Alzheimer's disease	0.000473	0.0846	CrCbGaD
Milnacipran—Anorexia—Donepezil—Alzheimer's disease	0.000472	0.00179	CcSEcCtD
Milnacipran—Hypersensitivity—Galantamine—Alzheimer's disease	0.000471	0.00178	CcSEcCtD
Milnacipran—Chest pain—Memantine—Alzheimer's disease	0.000469	0.00178	CcSEcCtD
Milnacipran—Anxiety—Memantine—Alzheimer's disease	0.000467	0.00177	CcSEcCtD
Milnacipran—Convulsion—Rivastigmine—Alzheimer's disease	0.000467	0.00177	CcSEcCtD
Milnacipran—Hypertension—Rivastigmine—Alzheimer's disease	0.000465	0.00176	CcSEcCtD
Milnacipran—Hypotension—Donepezil—Alzheimer's disease	0.000462	0.00175	CcSEcCtD
Milnacipran—Chest pain—Rivastigmine—Alzheimer's disease	0.000459	0.00174	CcSEcCtD
Milnacipran—Dry mouth—Memantine—Alzheimer's disease	0.000458	0.00174	CcSEcCtD
Milnacipran—Asthenia—Galantamine—Alzheimer's disease	0.000458	0.00174	CcSEcCtD
Milnacipran—Anxiety—Rivastigmine—Alzheimer's disease	0.000457	0.00173	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000455	0.00172	CcSEcCtD
Milnacipran—Dry mouth—Rivastigmine—Alzheimer's disease	0.000449	0.0017	CcSEcCtD
Milnacipran—Insomnia—Donepezil—Alzheimer's disease	0.000448	0.0017	CcSEcCtD
Milnacipran—Infection—Memantine—Alzheimer's disease	0.000446	0.00169	CcSEcCtD
Milnacipran—Paraesthesia—Donepezil—Alzheimer's disease	0.000444	0.00168	CcSEcCtD
Milnacipran—Shock—Memantine—Alzheimer's disease	0.000442	0.00167	CcSEcCtD
Milnacipran—Dyspnoea—Donepezil—Alzheimer's disease	0.000441	0.00167	CcSEcCtD
Milnacipran—Nervous system disorder—Memantine—Alzheimer's disease	0.000441	0.00167	CcSEcCtD
Milnacipran—Somnolence—Donepezil—Alzheimer's disease	0.00044	0.00167	CcSEcCtD
Milnacipran—Thrombocytopenia—Memantine—Alzheimer's disease	0.00044	0.00167	CcSEcCtD
Milnacipran—Tachycardia—Memantine—Alzheimer's disease	0.000439	0.00166	CcSEcCtD
Milnacipran—Diarrhoea—Galantamine—Alzheimer's disease	0.000437	0.00165	CcSEcCtD
Milnacipran—Infection—Rivastigmine—Alzheimer's disease	0.000437	0.00165	CcSEcCtD
Milnacipran—Skin disorder—Memantine—Alzheimer's disease	0.000436	0.00165	CcSEcCtD
Milnacipran—Dyspepsia—Donepezil—Alzheimer's disease	0.000436	0.00165	CcSEcCtD
Milnacipran—Hyperhidrosis—Memantine—Alzheimer's disease	0.000434	0.00165	CcSEcCtD
Milnacipran—Shock—Rivastigmine—Alzheimer's disease	0.000433	0.00164	CcSEcCtD
Milnacipran—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000431	0.00163	CcSEcCtD
Milnacipran—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00043	0.00163	CcSEcCtD
Milnacipran—Decreased appetite—Donepezil—Alzheimer's disease	0.00043	0.00163	CcSEcCtD
Milnacipran—Tachycardia—Rivastigmine—Alzheimer's disease	0.000429	0.00162	CcSEcCtD
Milnacipran—Anorexia—Memantine—Alzheimer's disease	0.000428	0.00162	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000427	0.00162	CcSEcCtD
Milnacipran—Skin disorder—Rivastigmine—Alzheimer's disease	0.000427	0.00162	CcSEcCtD
Milnacipran—Fatigue—Donepezil—Alzheimer's disease	0.000427	0.00162	CcSEcCtD
Milnacipran—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000425	0.00161	CcSEcCtD
Milnacipran—Constipation—Donepezil—Alzheimer's disease	0.000423	0.0016	CcSEcCtD
Milnacipran—Dizziness—Galantamine—Alzheimer's disease	0.000422	0.0016	CcSEcCtD
Milnacipran—Hypotension—Memantine—Alzheimer's disease	0.00042	0.00159	CcSEcCtD
Milnacipran—Anorexia—Rivastigmine—Alzheimer's disease	0.000419	0.00159	CcSEcCtD
Milnacipran—Hypotension—Rivastigmine—Alzheimer's disease	0.000411	0.00156	CcSEcCtD
Milnacipran—Insomnia—Memantine—Alzheimer's disease	0.000406	0.00154	CcSEcCtD
Milnacipran—Vomiting—Galantamine—Alzheimer's disease	0.000406	0.00154	CcSEcCtD
Milnacipran—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000405	0.00153	CcSEcCtD
Milnacipran—Paraesthesia—Memantine—Alzheimer's disease	0.000404	0.00153	CcSEcCtD
Milnacipran—Rash—Galantamine—Alzheimer's disease	0.000403	0.00152	CcSEcCtD
Milnacipran—Dermatitis—Galantamine—Alzheimer's disease	0.000402	0.00152	CcSEcCtD
Milnacipran—Dyspnoea—Memantine—Alzheimer's disease	0.000401	0.00152	CcSEcCtD
Milnacipran—Headache—Galantamine—Alzheimer's disease	0.0004	0.00151	CcSEcCtD
Milnacipran—Somnolence—Memantine—Alzheimer's disease	0.0004	0.00151	CcSEcCtD
Milnacipran—Insomnia—Rivastigmine—Alzheimer's disease	0.000398	0.00151	CcSEcCtD
Milnacipran—Dyspepsia—Memantine—Alzheimer's disease	0.000396	0.0015	CcSEcCtD
Milnacipran—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000395	0.00149	CcSEcCtD
Milnacipran—Urticaria—Donepezil—Alzheimer's disease	0.000393	0.00149	CcSEcCtD
Milnacipran—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000392	0.00148	CcSEcCtD
Milnacipran—Abdominal pain—Donepezil—Alzheimer's disease	0.000391	0.00148	CcSEcCtD
Milnacipran—Body temperature increased—Donepezil—Alzheimer's disease	0.000391	0.00148	CcSEcCtD
Milnacipran—Somnolence—Rivastigmine—Alzheimer's disease	0.000391	0.00148	CcSEcCtD
Milnacipran—Decreased appetite—Memantine—Alzheimer's disease	0.000391	0.00148	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000388	0.00147	CcSEcCtD
Milnacipran—Fatigue—Memantine—Alzheimer's disease	0.000387	0.00147	CcSEcCtD
Milnacipran—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000387	0.00147	CcSEcCtD
Milnacipran—Constipation—Memantine—Alzheimer's disease	0.000384	0.00146	CcSEcCtD
Milnacipran—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000382	0.00145	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00038	0.00144	CcSEcCtD
Milnacipran—Nausea—Galantamine—Alzheimer's disease	0.000379	0.00144	CcSEcCtD
Milnacipran—Fatigue—Rivastigmine—Alzheimer's disease	0.000379	0.00144	CcSEcCtD
Milnacipran—Constipation—Rivastigmine—Alzheimer's disease	0.000376	0.00142	CcSEcCtD
Milnacipran—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000367	0.00139	CcSEcCtD
Milnacipran—Hypersensitivity—Donepezil—Alzheimer's disease	0.000365	0.00138	CcSEcCtD
Milnacipran—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000359	0.00136	CcSEcCtD
Milnacipran—Urticaria—Memantine—Alzheimer's disease	0.000357	0.00135	CcSEcCtD
Milnacipran—Abdominal pain—Memantine—Alzheimer's disease	0.000355	0.00135	CcSEcCtD
Milnacipran—Body temperature increased—Memantine—Alzheimer's disease	0.000355	0.00135	CcSEcCtD
Milnacipran—Asthenia—Donepezil—Alzheimer's disease	0.000355	0.00134	CcSEcCtD
Milnacipran—Pruritus—Donepezil—Alzheimer's disease	0.00035	0.00133	CcSEcCtD
Milnacipran—Urticaria—Rivastigmine—Alzheimer's disease	0.000349	0.00132	CcSEcCtD
Milnacipran—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000348	0.00132	CcSEcCtD
Milnacipran—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000348	0.00132	CcSEcCtD
Milnacipran—Diarrhoea—Donepezil—Alzheimer's disease	0.000339	0.00128	CcSEcCtD
Milnacipran—Hypersensitivity—Memantine—Alzheimer's disease	0.000331	0.00125	CcSEcCtD
Milnacipran—Dizziness—Donepezil—Alzheimer's disease	0.000327	0.00124	CcSEcCtD
Milnacipran—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000324	0.00123	CcSEcCtD
Milnacipran—Asthenia—Memantine—Alzheimer's disease	0.000322	0.00122	CcSEcCtD
Milnacipran—Pruritus—Memantine—Alzheimer's disease	0.000318	0.0012	CcSEcCtD
Milnacipran—Asthenia—Rivastigmine—Alzheimer's disease	0.000315	0.00119	CcSEcCtD
Milnacipran—Vomiting—Donepezil—Alzheimer's disease	0.000315	0.00119	CcSEcCtD
Milnacipran—SLC6A4—Synaptic Vesicle Pathway—SYP—Alzheimer's disease	0.000314	0.0796	CbGpPWpGaD
Milnacipran—Rash—Donepezil—Alzheimer's disease	0.000312	0.00118	CcSEcCtD
Milnacipran—Dermatitis—Donepezil—Alzheimer's disease	0.000312	0.00118	CcSEcCtD
Milnacipran—Pruritus—Rivastigmine—Alzheimer's disease	0.000311	0.00118	CcSEcCtD
Milnacipran—Headache—Donepezil—Alzheimer's disease	0.00031	0.00117	CcSEcCtD
Milnacipran—Diarrhoea—Memantine—Alzheimer's disease	0.000307	0.00116	CcSEcCtD
Milnacipran—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000301	0.00114	CcSEcCtD
Milnacipran—Dizziness—Memantine—Alzheimer's disease	0.000297	0.00113	CcSEcCtD
Milnacipran—Nausea—Donepezil—Alzheimer's disease	0.000294	0.00111	CcSEcCtD
Milnacipran—Dizziness—Rivastigmine—Alzheimer's disease	0.000291	0.0011	CcSEcCtD
Milnacipran—Vomiting—Memantine—Alzheimer's disease	0.000286	0.00108	CcSEcCtD
Milnacipran—Rash—Memantine—Alzheimer's disease	0.000283	0.00107	CcSEcCtD
Milnacipran—Dermatitis—Memantine—Alzheimer's disease	0.000283	0.00107	CcSEcCtD
Milnacipran—Headache—Memantine—Alzheimer's disease	0.000282	0.00107	CcSEcCtD
Milnacipran—Vomiting—Rivastigmine—Alzheimer's disease	0.00028	0.00106	CcSEcCtD
Milnacipran—Rash—Rivastigmine—Alzheimer's disease	0.000277	0.00105	CcSEcCtD
Milnacipran—Dermatitis—Rivastigmine—Alzheimer's disease	0.000277	0.00105	CcSEcCtD
Milnacipran—Headache—Rivastigmine—Alzheimer's disease	0.000275	0.00104	CcSEcCtD
Milnacipran—Nausea—Memantine—Alzheimer's disease	0.000267	0.00101	CcSEcCtD
Milnacipran—Nausea—Rivastigmine—Alzheimer's disease	0.000261	0.000989	CcSEcCtD
Milnacipran—SLC6A4—Synaptic Vesicle Pathway—SLC18A3—Alzheimer's disease	0.000256	0.0649	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—PVRL2—Alzheimer's disease	0.000231	0.0584	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—PVRL2—Alzheimer's disease	0.000198	0.0502	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—ACHE—Alzheimer's disease	0.000173	0.0438	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—ACHE—Alzheimer's disease	0.000149	0.0376	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—SLC6A4—Alzheimer's disease	0.000137	0.0346	CbGpPWpGaD
Milnacipran—SLC6A4—Serotonin Transporter Activity—IL1B—Alzheimer's disease	0.000136	0.0343	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.000132	0.0334	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	8.68e-05	0.022	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	8.64e-05	0.0219	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	7.38e-05	0.0187	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	7.38e-05	0.0187	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	7.15e-05	0.0181	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	7.03e-05	0.0178	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	6.28e-05	0.0159	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	5.99e-05	0.0152	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	5.9e-05	0.0149	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	5.79e-05	0.0147	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—IL1B—Alzheimer's disease	5.77e-05	0.0146	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	5.3e-05	0.0134	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	5.09e-05	0.0129	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—IL1B—Alzheimer's disease	4.96e-05	0.0126	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	4.92e-05	0.0125	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	4.81e-05	0.0122	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TF—Alzheimer's disease	4.76e-05	0.012	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	4.39e-05	0.0111	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	4.35e-05	0.011	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—SST—Alzheimer's disease	4.35e-05	0.011	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CST3—Alzheimer's disease	4.32e-05	0.011	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CHRNB2—Alzheimer's disease	4.32e-05	0.011	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—TNF—Alzheimer's disease	4.19e-05	0.0106	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC6A4—Alzheimer's disease	4.05e-05	0.0103	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CRH—Alzheimer's disease	3.93e-05	0.00994	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—NPS—Alzheimer's disease	3.72e-05	0.00943	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—TNF—Alzheimer's disease	3.6e-05	0.00912	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—HMOX1—Alzheimer's disease	3.51e-05	0.00888	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	3.34e-05	0.00846	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	3.25e-05	0.00822	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—CP—Alzheimer's disease	3.2e-05	0.00809	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—AGER—Alzheimer's disease	3.15e-05	0.00798	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	3.12e-05	0.00789	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—NGFR—Alzheimer's disease	3.05e-05	0.00772	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	3.04e-05	0.0077	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—HMOX1—Alzheimer's disease	3.02e-05	0.00764	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	3.02e-05	0.00763	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	2.88e-05	0.0073	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	2.74e-05	0.00695	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	2.73e-05	0.00691	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—AGER—Alzheimer's disease	2.71e-05	0.00686	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	2.59e-05	0.00655	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PRKCG—Alzheimer's disease	2.42e-05	0.00612	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	2.19e-05	0.00555	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—LEP—Alzheimer's disease	2.08e-05	0.00527	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—NOS2—Alzheimer's disease	1.94e-05	0.00491	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARG—Alzheimer's disease	1.81e-05	0.00459	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—GSK3B—Alzheimer's disease	1.8e-05	0.00457	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CREB1—Alzheimer's disease	1.79e-05	0.00453	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.63e-05	0.00412	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.62e-05	0.00411	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.62e-05	0.00411	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.38e-05	0.0035	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.38e-05	0.00349	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFB1—Alzheimer's disease	1.33e-05	0.00337	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—MAPK8—Alzheimer's disease	1.22e-05	0.00308	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.18e-05	0.00299	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFB1—Alzheimer's disease	1.15e-05	0.0029	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	9.66e-06	0.00245	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	9.52e-06	0.00241	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—TP53—Alzheimer's disease	8.49e-06	0.00215	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—IL6—Alzheimer's disease	7.77e-06	0.00197	CbGpPWpGaD
